COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
19/08/2026
Highest Q2 and H1 revenue in Company history , reflecting strength across all core segments and reaching a new milestone with an adjusted annualized revenue run-rate exceeding $75 million Continued progress toward [...]
SafeSpace Global and BMRT Security Enter Binding Exclusive Agreement to Advance Detection of Concealed Weapons and Drugs for America’s Schools and Correctional Facilities
19/08/2026
Using AI to spot the guns and drugs BEFORE they KILL. KNOXVILLE, Tenn., Aug. 19, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (“SafeSpace Global” or the “Company”), a publicly traded, multimodal [...]
DAZED INC. POWERING FORWARD: ANNOUNCES DALLAS EXPANSION BRINGING STORE COUNT TO 13, STRONGER Q2 2026 FINANCIALS, Q4 STOCK BUYBACK PLAN, AND DISTRIBUTION ACCELERATION
19/08/2026
Lazydaze Coffeeshop Expands to Dallas, Releases Q2 Reports and Capitalizes on Distribution Austin, Texas , Aug. 19, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE August 18, 2026 — Dazed Inc. (OTC: DAZD), formerly MedX [...]
BC health research pursues precision, genetics-based care for three conditions
19/08/2026
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) -- A person’s DNA can help predict suitable treatments, medications and nutrition for them, leading to better personalized care. Three Genome British Columbia [...]
Increased outlook for 2026
19/08/2026
Novonesis increases its full year 2026 organic sales growth outlook from 5-7% to now 7-8% based on a stronger performance so far in the year and the expectations for the rest of the year. Following the stronger sales [...]
Announcement of share buyback program
19/08/2026
The Board of Directors of Novonesis has approved an inaugural multi-year share buyback program in a total amount of EUR 1 billion to be initiated during the second half of 2026 and expected to be completed by the end of [...]
Interim report H1 2026
19/08/2026
Strong first half year at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% and the adjusted EBITDA margin expected at the higher end of the 37-38% range. Inaugural share buy-back program [...]
Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
19/08/2026
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is [...]
Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies
19/08/2026
Late-breaking Phase IV VICTORION-CHALLENGE data will evaluate Leqvio ® (inclisiran) vs. bempedoic acid in achieving LDL-C goals New AZALEA-TIMI 71 analyses will further characterize the bleeding profile of abelacimab in [...]
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
19/08/2026
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026 Presentation will provide additional analysis from the Phase IIa study of RESP-X in Pseudomonas aeruginosa -colonised [...]
Two physicians at The Wall Center named to America's Best Plastic Surgeons 2026 — a first for any Shreveport practice
18/08/2026
SHREVEPORT, La., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The Wall Center for Plastic Surgery announced today that two of its surgeons have been named to Newsweek 's America's Best Plastic Surgeons 2026 list, ranked in [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 14, 2026 it granted stock options to purchase an aggregate of 27,565 shares of [...]
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
18/08/2026
FULLERTON, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that its board of directors has adopted resolutions approving a reverse stock [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
FOSTER CITY, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective August 17, 2026, it granted stock options to purchase [...]
Acquisition of Own Shares
18/08/2026
Mechelen, Belgium; 18 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Iridex Reports Second Quarter 2026 Financial Results
18/08/2026
MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
18/08/2026
Event and Webcast to be held August 20th, 2026, 9:00 AM ET MILLBRAE, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated [...]
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
18/08/2026
Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead therapeutic program SARASOTA, FLA., Aug. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
WALTHAM, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]

Pages